Literature DB >> 16583042

Cost of schizophrenia: direct costs and use of resources in the State of São Paulo.

Raquel Jales Leitão1, Marcos Bosi Ferraz, Ana Cristina Chaves, Jair J Mari.   

Abstract

OBJECTIVE: To estimate the direct costs of schizophrenia for the public sector.
METHODS: A study was carried out in the state of São Paulo, Brazil, during 1998. Data from the medical literature and governmental research bodies were gathered for estimating the total number of schizophrenia patients covered by the Brazilian Unified Health System. A decision tree was built based on an estimated distribution of patients under different types of psychiatric care. Medical charts from public hospitals and outpatient services were used to estimate the resources used over a one-year period. Direct costs were calculated by attributing monetary values for each resource used.
RESULTS: Of all patients, 81.5% were covered by the public sector and distributed as follows: 6.0% in psychiatric hospital admissions, 23.0% in outpatient care, and 71.0% without regular treatment. The total direct cost of schizophrenia was US $191,781,327 (2.2% of the total health care expenditure in the state). Of this total, 11.0% was spent on outpatient care and 79.2% went for inpatient care.
CONCLUSIONS: Most schizophrenia patients in the state of São Paulo receive no regular treatment. The study findings point out to the importance of investing in research aimed at improving the resource allocation for the treatment of mental disorders in Brazil.

Entities:  

Mesh:

Year:  2006        PMID: 16583042     DOI: 10.1590/s0034-89102006000200017

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  7 in total

1.  Public conceptions of schizophrenia in urban Brazil : symptom identification and causal attributions.

Authors:  Erica de Toledo Piza Peluso; Clóvis de Araújo Peres; Sérgio Luís Blay
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05-23       Impact factor: 4.328

2.  Barriers in the mind: promoting an economic case for mental health in low- and middle-income countries.

Authors:  David McDaid; Martin Knapp; Shoba Raja
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

3.  Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia.

Authors:  Mário Rodrigues Louzã; Helio Elkis; Sandra Ruschel; Irismar Reis de Oliveira; Rodrigo Affonseca Bressan; Paulo Belmonte-de-Abreu; Hamilton Grabowski; José Carlos Appolinário
Journal:  Neuropsychiatr Dis Treat       Date:  2011-06-23       Impact factor: 2.570

Review 4.  Health Policy on the pages of Revista de Saúde Pública.

Authors:  Aylene Bousquat; Oswaldo Yoshimi Tanaka
Journal:  Rev Saude Publica       Date:  2016-11-10       Impact factor: 2.106

5.  The mental health system in Brazil: Policies and future challenges.

Authors:  Mario D Mateus; Jair J Mari; Pedro Gg Delgado; Naomar Almeida-Filho; Thomas Barrett; Jeronimo Gerolin; Samuel Goihman; Denise Razzouk; Jorge Rodriguez; Renata Weber; Sergio B Andreoli; Shekhar Saxena
Journal:  Int J Ment Health Syst       Date:  2008-09-05

6.  Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil.

Authors:  Livia M M Pontes; Camila B Martins; Isabel C Napolitano; Juliana R Fonseca; Graça M R Oliveira; Sandra M K Iso; Anny K P M Menezes; Adriana D B Vizzotto; Elaine S di Sarno; Hélio Elkis
Journal:  Schizophr Res Treatment       Date:  2013-10-30

Review 7.  Global economic burden of schizophrenia: a systematic review.

Authors:  Huey Yi Chong; Siew Li Teoh; David Bin-Chia Wu; Surachai Kotirum; Chiun-Fang Chiou; Nathorn Chaiyakunapruk
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-16       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.